Population
Patients with asthma and chronic obstructive airways disease, and airway smooth muscle models
Design
Review
Authors
Loading...
Does not alter current bronchodilator use; leaves open cGMP and potassium channel pathways for novel agent development.
This review highlights evolving understandings of airway smooth muscle relaxation mechanisms, including the roles of cGMP and potassium channels, which may guide future bronchodilator development.
Knox et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: